Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...
Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and ...
- Advancement reflects continued execution of capital-efficient development strategy leveraging POZ Platform™ - ...
A memo shows Jeffrey Epstein was the subject of a previously undisclosed U.S. Drug Enforcement Agency investigation targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results